Exact Sciences Corporation (EXAS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:07PM EDT. Market open.
| Previous close | 58.78 |
| Open | 58.00 |
| Bid | 59.25 x 600 |
| Ask | 59.53 x 600 |
| Day's range | 57.55 - 59.86 |
| 52-week range | 56.05 - 100.77 |
| Volume | |
| Avg. volume | 2,505,511 |
| Market cap | 10.921B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.13 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 90.76 |
ZacksExact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Exact Sciences (EXAS) closed at $63.24, marking a -0.46% move from the previous day.
Insider MonkeyHere’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
ZacksShould You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
Exact Sciences' (EXAS) first-quarter 2024 performance is expected to include gains from robust Cologuard uptake and continuing Oncotype DX growth, offset slightly by increasing operating costs.
© 2024 Yahoo. All rights reserved.